Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,065,387
Closed -$30.1M 804
2025
Q2
$30.1M Buy
+3,065,387
New +$25.4M 0.07% 211
2024
Q2
Sell
-3,450,689
Closed -$40.2M 745
2024
Q1
$40.2M Sell
3,450,689
-39,939
-1% -$442K 0.15% 172
2023
Q4
$39M Buy
3,490,628
+1,254,823
+56% +$11.5M 0.15% 168
2023
Q3
$34.5M Sell
2,235,805
-402,694
-15% -$6.76M 0.15% 173
2023
Q2
$50M Buy
2,638,499
+543,456
+26% +$9.54M 0.21% 133
2023
Q1
$31.9M Buy
2,095,043
+194,511
+10% +$2.54M 0.16% 167
2022
Q4
$24.2M Buy
+1,900,532
New +$17.1M 0.15% 162

Other funds holding ETNB

Holocene Advisors's ETNB Position: Q3 2025 in Review

Holocene Advisors sold out of 89bio (ETNB) in Q3 2025, closing a stake of 3,065,387 shares — an estimated $30.1M sold.

Holocene Advisors first reported a position in ETNB in Q4 2022 and held it in 7 quarters. The position peaked at $50M in Q2 2023. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Holocene Advisors reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Holocene Advisors sold 3,065,387 89bio shares in Q3 2025, an estimated $30.1M.
  • Holocene Advisors first reported a position in 89bio in Q4 2022 and held it in 7 quarters.
  • Holocene Advisors's 89bio position peaked at $50M in Q2 2023.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Holocene Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.